Search results for "valence"

showing 10 items of 2732 documents

Oral cancer: A multicenter study

2017

Background To determine the prevalence and clinicopathologic features of the oral cancer patients. Material and Methods Biopsy records of the participating institutions were reviewed for oral cancer cases diagnosed from 2005 to 2014. Demographic data and site of the lesions were collected. Sites of the lesion were subdivided into lip, tongue, floor of the mouth, gingiva, alveolar mucosa, palate, buccal/labial mucosa, maxilla and mandible. Oral cancer was subdivided into 7 categories: epithelial tumors, salivary gland tumors, hematologic tumors, bone tumors, mesenchymal tumors, odontogenic tumors, and others. Data were analyzed by descriptive statistics using SPSS software version 17.0. Resu…

AdultMaleCanadamedicine.medical_specialtyAsiaAdolescentYoung Adult03 medical and health sciences0302 clinical medicinestomatognathic systemTongueMucoepidermoid carcinomaPrevalencemedicineHumansOral mucosaYoung adultLabial MucosaChildGeneral DentistryAlveolar mucosaAgedAged 80 and overMouth neoplasmOral Medicine and Pathologybusiness.industryResearchCancer030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologystomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyChild Preschool030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASFemaleMouth NeoplasmsSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Smoking and Helicobacter pylori infection: an individual participant pooled analysis (Stomach Cancer Pooling- StoP Project)

2019

Smoking has been associated with acquisition and increased persistence of Helicobacter pylori infection, as well as with lower effectiveness of its eradication. A greater prevalence of infection among smokers could contribute to the increased risk for gastric cancer. We aimed to estimate the association between smoking and seropositivity to H. pylori through an individual participant data pooled analysis using controls from 14 case- control studies participating in the Stomach Cancer Pooling Project. Summary odds ratios and prevalence ratios (PRs), adjusted for age, sex and social class, and the corresponding 95% confidence intervals (CIs) were estimated through random-effects meta-analysis…

AdultMaleCancer ResearchEpidemiologyPoolingserologyconsortiumRisk AssessmentsmokingHelicobacter Infections03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsStomach NeoplasmsPrevalenceTobacco SmokingmedicineHumanspooled analysi030212 general & internal medicineStomach cancerAgedSmokersHelicobacter pyloribusiness.industryAge FactorsPublic Health Environmental and Occupational HealthCase-control studyCancerindividual participant dataPublication biasOdds ratioMiddle Agedmedicine.diseaseConfidence intervalOncologyGastric MucosaCase-Control Studies030220 oncology & carcinogenesisFemalebusinessRisk assessmentDemographyEuropean Journal of Cancer Prevention
researchProduct

Smoking in Italy 2013-2014, with a focus on the young.

2015

Aims To update smoking prevalence trends in Italy among adult and young populations; to determine the recent spread, particularly among young smokers, of roll-your-own (RYO) cigarettes (which cost approximately half the price of manufactured cigarettes); and to evaluate the effects of 2013 legislation increasing the minimum tobacco purchasing age from 16 to 18 years in Italy. Methods Two surveys on smoking were conducted in 2013 and 2014 in Italy, on a total sample of 6052 individuals, representative each year of the national population aged ≥15 years, where we collected data on type of tobacco most frequently smoked and on the perception of the enforcement of the tobacco sales-to-minors le…

AdultMaleCancer ResearchFocus (computing)Adolescentbusiness.industrySmokingCommerceGeneral MedicineTobacco ProductsSmoking prevalenceYoung AdultOncologyItalyEnvironmental healthPrevalenceMedicineHumansFemaleSmoking CessationSelf ReportbusinessTumori
researchProduct

Time trends and short term projections of cancer prevalence in France

2018

IF 2.888 (2017); International audience; BackgroundThis study analyzes time trends in cancer prevalence in France and provides short-term projections up to the year 2017. The 15-year prevalence for 24 cancers was estimated from the French cancer registries network (FRANCIM) incidence and survival data.MethodWe estimated prevalence using the P = I × S relationship, with flexible modeling of incidence and survival. Based on observations of the incidence and survival up to 2010, different scenarios for evolution up to 2017 were studied, combining stable and dynamic incidence and survival. The determinants of variations in prevalence (incidence, survival and demography) were quantified.ResultsA…

AdultMaleCancer ResearchTime FactorsAdolescentEpidemiologyPopulation[SDV.CAN]Life Sciences [q-bio]/Cancer030501 epidemiologyProjection scenariosYoung Adult03 medical and health sciences0302 clinical medicineSurvival dataNeoplasmsPrevalencemedicineHumansRegistrieseducationCancer prevalenceAgedAged 80 and overeducation.field_of_studybusiness.industryTime trendsIncidenceIncidence (epidemiology)CancerTime trendsMiddle AgedPrognosismedicine.diseaseShort-term projections3. Good healthSurvival RateOncologyDemographic change030220 oncology & carcinogenesisFemaleFranceFlexible models0305 other medical sciencebusinessDemographyCancer Epidemiology
researchProduct

Cyclosporin- and nifedipine-induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters, a…

1996

The factors associated with cyclosporin A (CsA)- and nifedipine (Nif)-induced gingival overgrowth were investigated in 113 renal transplant recipients receiving CsA alone (Group 1) [n = 61], CsA and Nif (Group 2) [n = 28], or azathioprine (Aza) (Control Group) [n = 24]. Periodontal and pharmacological parameters were assessed for each patient. The patients with a gingival overgrowth index (GOI) score1 were considered responders (R); those with a score/= 1 were non-responders (NR). Gingival overgrowth occurred in 33.7% of the patients in Groups 1 and 2; 60% of the responders were receiving CsA+Nif. In R, no relationship was found between the GOI and the periodontal and pharmacological parame…

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentNifedipineAzathioprineGastroenterologyPathology and Forensic MedicinePathogenesisNifedipineHLA AntigensInternal medicineCyclosporin aAzathioprinePrevalencemedicineHumansPeriodontal PocketDental CalculusChildSalivaKidney transplantationKidneyHLA-A AntigensGingival Overgrowthbusiness.industryDental Plaque IndexMiddle AgedCalcium Channel Blockersmedicine.diseaseGingivitisKidney TransplantationTransplantationEndocrinologymedicine.anatomical_structureOtorhinolaryngologyToxicityCyclosporineIrritantsPeriodonticsFemaleDisease SusceptibilityPeriodontal IndexOral SurgerybusinessImmunosuppressive Agentsmedicine.drugJournal of Oral Pathology and Medicine
researchProduct

Prevalence of patients with colorectal cancer requiring follow-up or active treatment

2008

Abstract Introduction The objective of this study was to estimate prevalence of colorectal cancers requiring care or follow-up. Materials and methods Prevalence was observed in 2005 on the population-based digestive cancer registry of Burgundy (France). Total and 5-year partial prevalences were calculated. The prevalence of patients requiring follow-up was estimated using non-mixture cure models. The prevalence of patients with recurrence was estimated using annual recurrence rates. Results Total prevalence was 262,244 cases in France. The mean variation in 5-year partial prevalence between successive 5-year periods was +8.0%. Time to cure was estimated to be 9.3 years, suggesting that foll…

AdultMaleCancer Researchmedicine.medical_specialtyColorectal cancerPopulationPrevalenceInternal medicineEpidemiologyPrevalencemedicineHumansRegistrieseducationSurvival rateAgededucation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)CancerMiddle Agedmedicine.diseaseSurgeryCancer registrySurvival RateOncologyFemaleFranceNeoplasm Recurrence LocalColorectal NeoplasmsbusinessEuropean Journal of Cancer
researchProduct

Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology P…

2014

Purpose The prevalence of anaplastic lymphoma kinase (ALK) gene fusion (ALK positivity) in early-stage non–small-cell lung cancer (NSCLC) varies by population examined and detection method used. The Lungscape ALK project was designed to address the prevalence and prognostic impact of ALK positivity in resected lung adenocarcinoma in a primarily European population. Methods Analysis of ALK status was performed by immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) in tissue sections of 1,281 patients with adenocarcinoma in the European Thoracic Oncology Platform Lungscape iBiobank. Positive patients were matched with negative patients in a 1:2 ratio, both for IHC and for …

AdultMaleCancer Researchmedicine.medical_specialtyPathologyLung NeoplasmsPopulation610 Medicine & healthAdenocarcinoma of LungAdenocarcinomaGastroenterologyCohort Studies10049 Institute of Pathology and Molecular Pathologyhemic and lymphatic diseasesThoracic OncologyInternal medicinePrevalencemedicineHumansAnaplastic lymphoma kinase1306 Cancer ResearchAnaplastic Lymphoma KinaseLung cancereducationIn Situ Hybridization FluorescenceAgedNeoplasm Stagingeducation.field_of_studyLungbusiness.industryALK-PositiveReceptor Protein-Tyrosine KinasesMiddle Agedmedicine.diseaseImmunohistochemistryEuropeTreatment Outcomemedicine.anatomical_structureOncology10032 Clinic for Oncology and HematologyImmunohistochemistryAdenocarcinoma2730 OncologyFemalebusiness
researchProduct

Posttraumatic stress, depression and anxiety among adult long-term survivors of cancer in adolescence.

2010

Abstract Background To determine the prevalence of posttraumatic stress, depression and anxiety in adults who have survived cancer (⩾5 years) diagnosed in adolescence, as compared to healthy controls. Patients and methods Survivors (n = 820) of cancer during adolescence (age M = 30.4 ± 6.0 years; M = 13.7 ± 6.0 years since diagnosis) and 1027 matched controls without history of cancer (age M = 31.5 ± 6.9 years) completed standardised questionnaires measuring posttraumatic stress, depression and anxiety. Additionally, sub-groups of 202 survivors and 140 controls with elevated scores received structured interviews to ascertain DSM-IV-diagnoses. Results A total of 22.4% of the survivors report…

AdultMaleCancer Researchmedicine.medical_specialtyPediatricsAdolescentStress Disorders Post-TraumaticYoung AdultNeoplasmsSurveys and QuestionnairesEpidemiologyPrevalenceMedicineHumansSurvivorsYoung adultPsychiatryDepression (differential diagnoses)Analysis of VarianceDepressive Disorderbusiness.industryCase-control studyOdds ratioMiddle Agedmedicine.diseaseAnxiety DisordersOncologyCase-Control StudiesAnxietyFemalemedicine.symptombusinessPsychosocialAnxiety disorderEuropean journal of cancer (Oxford, England : 1990)
researchProduct

New levothyroxine formulation meeting 95–105% specification over the whole shelf-life: results from two pharmacokinetic trials

2016

Small levothyroxine (L-T4) dose changes can lead to significant clinical effects. To ensure thyroid hormone levels are safely maintained, authorities are increasingly adopting stricter potency specifications for L-T4, the most stringent of these being 95-105% of the labeled dose over the whole shelf-life. Levothyroxine sodium (Euthyrox, Eutirox, Lévothyrox ) has been reformulated, and two studies performed, to ensure bioequivalence to the currently marketed formulation and dosage form proportionality of the new formulation.The bioequivalence study was an open-label, randomized, single-dose, two-period, two-sequence crossover comparing the highest dosage strengths of the currently marketed a…

AdultMaleChemistry PharmaceuticalLevothyroxine030209 endocrinology & metabolismPharmacologyBioequivalenceShelf lifeDosage form03 medical and health sciences0302 clinical medicinePharmacokineticsHumansMedicinePotencyCross-Over Studiesbusiness.industryGeneral MedicineCrossover studyThyroxineTherapeutic EquivalencyArea Under Curve030220 oncology & carcinogenesisFemalebusinessTabletsmedicine.drugLevothyroxine SodiumCurrent Medical Research and Opinion
researchProduct

Associations between adverse childhood experiences and adversities later in life. Survey data from a high-risk Norwegian sample

2019

Abstract Background A history of childhood abuse and neglect (CAN) is associated with exposure to later negative life events. CAN at an early age, multiple cooccurring exposures (cumulative events), and a high severity and frequency of exposure have potential detrimental long-term effects. Objective The present study examines the relationship between the severity of CAN and the prevalence of school difficulties and hardship at school, adult adversity and mental health. Participants and Settings: Participants were recruited from in- and outpatient mental health or substance abuse treatment facilities, child protective services (CPS), and prisons (N = 809, age range = 13–66, mean age = 27.62,…

AdultMaleChild abuse050103 clinical psychologyAdolescentmedia_common.quotation_subjectPoison controlSuicide preventionOccupational safety and healthNeglectAdverse Childhood ExperiencesRisk FactorsSurveys and QuestionnairesInjury preventionPrevalenceDevelopmental and Educational PsychologyHumansMedicineVDP::Medisinske Fag: 7000501 psychology and cognitive sciencesChild AbuseChildmedia_commonLearning DisabilitiesNorwaybusiness.industry05 social sciencesMental healthbarnemishandlingPsychiatry and Mental healthMental HealthRelative riskPediatrics Perinatology and Child HealthFemale:Social science: 200::Social work: 360 [VDP]business050104 developmental & child psychologyClinical psychology
researchProduct